Perfluorodecalin

DB16292InvestigationalSmall molecule

Perfluorodecalin is under investigation in clinical trial NCT03668665 (Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh...

Formula / weight: C₁₀F₁₈ · 462.081 g/mol (avg)
Also known as: Acri-deca · Fluosol da perfluorodecalin · Octadecafluorodecahydronaphthalene · Perflunafene · Perftoran component perfluorodecalin
Code names: NSC-97066

Resolves to

Compound

UNII54A06VV62NCAS306-94-5ChEMBLCHEMBL1371129ChEBI38848

Clinical / RWD

RxNorm2462501

Structure

InChIKeyUWEYRJFJVCLAGH-UHFFFAOYSA-NSMILESFC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F

What you can answer from here — as of September 15, 2026

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Perfluorodecalin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account